PMC:7647877 / 9492-9871
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T173","span":{"begin":70,"end":82},"obj":"Body_part"},{"id":"T174","span":{"begin":89,"end":112},"obj":"Body_part"},{"id":"T175","span":{"begin":100,"end":112},"obj":"Body_part"},{"id":"T176","span":{"begin":135,"end":149},"obj":"Body_part"},{"id":"T177","span":{"begin":151,"end":153},"obj":"Body_part"},{"id":"T178","span":{"begin":155,"end":166},"obj":"Body_part"},{"id":"T179","span":{"begin":168,"end":171},"obj":"Body_part"},{"id":"T180","span":{"begin":270,"end":275},"obj":"Body_part"},{"id":"T181","span":{"begin":281,"end":300},"obj":"Body_part"},{"id":"T182","span":{"begin":296,"end":300},"obj":"Body_part"},{"id":"T183","span":{"begin":306,"end":325},"obj":"Body_part"},{"id":"T184","span":{"begin":313,"end":325},"obj":"Body_part"}],"attributes":[{"id":"A173","pred":"fma_id","subj":"T173","obj":"http://purl.org/sig/ont/fma/fma62869"},{"id":"A174","pred":"fma_id","subj":"T174","obj":"http://purl.org/sig/ont/fma/fma70573"},{"id":"A175","pred":"fma_id","subj":"T175","obj":"http://purl.org/sig/ont/fma/fma62870"},{"id":"A176","pred":"fma_id","subj":"T176","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A177","pred":"fma_id","subj":"T177","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A178","pred":"fma_id","subj":"T178","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A179","pred":"fma_id","subj":"T179","obj":"http://purl.org/sig/ont/fma/fma84079"},{"id":"A180","pred":"fma_id","subj":"T180","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A181","pred":"fma_id","subj":"T181","obj":"http://purl.org/sig/ont/fma/fma63147"},{"id":"A182","pred":"fma_id","subj":"T182","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A183","pred":"fma_id","subj":"T183","obj":"http://purl.org/sig/ont/fma/fma70572"},{"id":"A184","pred":"fma_id","subj":"T184","obj":"http://purl.org/sig/ont/fma/fma62870"}],"text":"Graphical representation of antiviral SARS-Coronavirus 2 immunity. B: B lymphocyte; CTL: cytotoxic; T lymphocyte; IFN: interferon; Ig: immunoglobulin; IL: interleukin; MHC: major histocompatibility class; NFκB: nuclear factor kappa-light- chain- enhancer of activated B cells; NK: natural killer cell; Th: helper T lymphocyte; TLR: Toll-like receptor; TNF: tumour necrosis factor"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T40","span":{"begin":38,"end":42},"obj":"Disease"}],"attributes":[{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Graphical representation of antiviral SARS-Coronavirus 2 immunity. B: B lymphocyte; CTL: cytotoxic; T lymphocyte; IFN: interferon; Ig: immunoglobulin; IL: interleukin; MHC: major histocompatibility class; NFκB: nuclear factor kappa-light- chain- enhancer of activated B cells; NK: natural killer cell; Th: helper T lymphocyte; TLR: Toll-like receptor; TNF: tumour necrosis factor"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T172","span":{"begin":67,"end":71},"obj":"http://purl.obolibrary.org/obo/CLO_0001869"},{"id":"T173","span":{"begin":208,"end":209},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T174","span":{"begin":258,"end":267},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T175","span":{"begin":268,"end":275},"obj":"http://purl.obolibrary.org/obo/CL_0000236"},{"id":"T176","span":{"begin":281,"end":300},"obj":"http://purl.obolibrary.org/obo/CL_0000623"},{"id":"T177","span":{"begin":306,"end":325},"obj":"http://purl.obolibrary.org/obo/CL_0000912"}],"text":"Graphical representation of antiviral SARS-Coronavirus 2 immunity. B: B lymphocyte; CTL: cytotoxic; T lymphocyte; IFN: interferon; Ig: immunoglobulin; IL: interleukin; MHC: major histocompatibility class; NFκB: nuclear factor kappa-light- chain- enhancer of activated B cells; NK: natural killer cell; Th: helper T lymphocyte; TLR: Toll-like receptor; TNF: tumour necrosis factor"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T112","span":{"begin":28,"end":37},"obj":"Chemical"},{"id":"T113","span":{"begin":119,"end":129},"obj":"Chemical"},{"id":"T114","span":{"begin":151,"end":153},"obj":"Chemical"},{"id":"T116","span":{"begin":205,"end":207},"obj":"Chemical"},{"id":"T119","span":{"begin":302,"end":304},"obj":"Chemical"}],"attributes":[{"id":"A112","pred":"chebi_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A113","pred":"chebi_id","subj":"T113","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A114","pred":"chebi_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A115","pred":"chebi_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A116","pred":"chebi_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/CHEBI_141424"},{"id":"A117","pred":"chebi_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/CHEBI_25573"},{"id":"A118","pred":"chebi_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/CHEBI_1224"},{"id":"A119","pred":"chebi_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/CHEBI_33385"}],"text":"Graphical representation of antiviral SARS-Coronavirus 2 immunity. B: B lymphocyte; CTL: cytotoxic; T lymphocyte; IFN: interferon; Ig: immunoglobulin; IL: interleukin; MHC: major histocompatibility class; NFκB: nuclear factor kappa-light- chain- enhancer of activated B cells; NK: natural killer cell; Th: helper T lymphocyte; TLR: Toll-like receptor; TNF: tumour necrosis factor"}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T9","span":{"begin":357,"end":363},"obj":"Phenotype"}],"attributes":[{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"Graphical representation of antiviral SARS-Coronavirus 2 immunity. B: B lymphocyte; CTL: cytotoxic; T lymphocyte; IFN: interferon; Ig: immunoglobulin; IL: interleukin; MHC: major histocompatibility class; NFκB: nuclear factor kappa-light- chain- enhancer of activated B cells; NK: natural killer cell; Th: helper T lymphocyte; TLR: Toll-like receptor; TNF: tumour necrosis factor"}
LitCovid-PD-GO-BP
{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T55","span":{"begin":168,"end":171},"obj":"http://purl.obolibrary.org/obo/GO_0046776"},{"id":"T56","span":{"begin":364,"end":372},"obj":"http://purl.obolibrary.org/obo/GO_0070265"},{"id":"T57","span":{"begin":364,"end":372},"obj":"http://purl.obolibrary.org/obo/GO_0019835"},{"id":"T58","span":{"begin":364,"end":372},"obj":"http://purl.obolibrary.org/obo/GO_0008219"},{"id":"T59","span":{"begin":364,"end":372},"obj":"http://purl.obolibrary.org/obo/GO_0001906"}],"text":"Graphical representation of antiviral SARS-Coronavirus 2 immunity. B: B lymphocyte; CTL: cytotoxic; T lymphocyte; IFN: interferon; Ig: immunoglobulin; IL: interleukin; MHC: major histocompatibility class; NFκB: nuclear factor kappa-light- chain- enhancer of activated B cells; NK: natural killer cell; Th: helper T lymphocyte; TLR: Toll-like receptor; TNF: tumour necrosis factor"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T62","span":{"begin":67,"end":69},"obj":"Sentence"},{"id":"T63","span":{"begin":70,"end":331},"obj":"Sentence"},{"id":"T64","span":{"begin":332,"end":379},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Graphical representation of antiviral SARS-Coronavirus 2 immunity. B: B lymphocyte; CTL: cytotoxic; T lymphocyte; IFN: interferon; Ig: immunoglobulin; IL: interleukin; MHC: major histocompatibility class; NFκB: nuclear factor kappa-light- chain- enhancer of activated B cells; NK: natural killer cell; Th: helper T lymphocyte; TLR: Toll-like receptor; TNF: tumour necrosis factor"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"176","span":{"begin":352,"end":355},"obj":"Gene"},{"id":"177","span":{"begin":38,"end":56},"obj":"Species"},{"id":"178","span":{"begin":205,"end":209},"obj":"Gene"},{"id":"179","span":{"begin":119,"end":129},"obj":"Gene"},{"id":"180","span":{"begin":114,"end":117},"obj":"Gene"},{"id":"181","span":{"begin":357,"end":372},"obj":"Disease"}],"attributes":[{"id":"A176","pred":"tao:has_database_id","subj":"176","obj":"Gene:7124"},{"id":"A177","pred":"tao:has_database_id","subj":"177","obj":"Tax:2697049"},{"id":"A178","pred":"tao:has_database_id","subj":"178","obj":"Gene:4790"},{"id":"A179","pred":"tao:has_database_id","subj":"179","obj":"Gene:3439"},{"id":"A180","pred":"tao:has_database_id","subj":"180","obj":"Gene:3439"},{"id":"A181","pred":"tao:has_database_id","subj":"181","obj":"MESH:D009336"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Graphical representation of antiviral SARS-Coronavirus 2 immunity. B: B lymphocyte; CTL: cytotoxic; T lymphocyte; IFN: interferon; Ig: immunoglobulin; IL: interleukin; MHC: major histocompatibility class; NFκB: nuclear factor kappa-light- chain- enhancer of activated B cells; NK: natural killer cell; Th: helper T lymphocyte; TLR: Toll-like receptor; TNF: tumour necrosis factor"}